• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Tumor Cell Lines

Daudi

  • BSL

    1

  • 122
The Daudi line was derived from a 16-year-old Black male with Burkitt’s lymphoma by E. Klein and G. Klein in May, 1967. The cells are negative for beta-2-microglobulin. They are positive for EBNA, VCA and Surface immunoglobulin (sIg+).
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options

The Daudi cell line, derived from a 16-year-old male Burkitt’s Lymphoma patient of African descent in 1967, primarily comprises B lymphoblasts and is characterized by its EBV-positive status along with the expression of mRNA for the proto-oncogene BCL2. Notably, these cells exhibit a deficiency in surface expression of HLA-ABC molecules due to the absence of beta-2-microglobulin, which is essential for the proper intracellular folding and processing of MHC class I molecules within the endoplasmic reticulum. It is advisable to employ a subculturing strategy with a split ratio ranging from 1:2 to 1:4 every 2-4 days, although initial growth of these cells may be relatively slow.

 

Why choose Daudi from AcceGen?

Daudi cells from AcceGen exhibit high viability and quality, ensuring robust experimental results. They are provided in a sterile state and rigorously screened for the absence of contaminants, including bacteria, yeast, fungi, mycoplasma, HIV, HBV, and HCV. Moreover, their identity is confirmed through STR analysis, further ensuring the reliability and authenticity of these cells for research applications.

Product Code

DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N

Species

Human

Cat.No

ABC-TC0204

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphoblast

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Blood

Disease

Burkitt’s Lymphoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Lymphoma Cell Lines

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

View More
View Product Image

Application

  • FOR RESEARCH USE ONLY

  • These well-characterized Daudi B lymphoblasts have been extensively used in the study of leukemogenesis, serving as a valuable model system for understanding the intricacies of B cell biology. Their utility extends to the analysis of B cell surface antigens, enabling the exploration of antigen expression and characterization. Moreover, Daudi cells are employed in the testing of cytotoxic drugs, mutational analysis, and investigations into apoptotic mechanisms, contributing significantly to research across these pivotal areas in oncology and immunology.

Inquiring Daudi

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

  • Human (1729)
  • Lymph (115)
  • Lymphoblast (57)
  • Lymphoma (56)
AcceGen Scroll Top Button